N-(1-Oxo-1,3-dihydroisobenzofuran-5-yl)acetamide

Catalog No.: 
ACVHEL013
CAS No.: 
207683-94-1
Molecular Formula: 
C10H9NO3
Molecular Weight: 
191.19
N-(1-Oxo-1,3-dihydroisobenzofuran-5-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$233.00InquiryInquiry
250mg95%$363.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(1-Oxo-1,3-dihydroisobenzofuran-5-yl)acetamide
IUPAC NameN-(1-oxo-1,3-dihydroisobenzofuran-5-yl)acetamide
MDL No.MFCD00465835
Molecular FormulaC10H9NO3
Molecular Weight191.19
SMILESO=C1OCC2=C1C=CC(NC(C)=O)=C2
InChI KeyXBLPTNDIRVYALA-UHFFFAOYSA-N
Synonym5-ACETAMIDO-PHTHALIDE;Acetamide, N-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-;N-(1-oxo-3H-2-benzofuran-5-yl)acetamide;N-(1-Oxo-1,3-dihydroisobenzofuran-5-yl)acetamide
CAS No.207683-94-1

Synthetic Route by SureRoute

1. ACVHEL013 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNIGX462 route compound structure diagram
    ACNIGX46265399-05-5In Stock
  4. Then
  5. ACVHEL013 route product structure diagram
    ACVHEL013207683-94-1
Inquiry

2. ACVHEL013 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACNIGX462 route compound structure diagram
    ACNIGX46265399-05-5In Stock
  6. Then
  7. ACVHEL013 route product structure diagram
    ACVHEL013207683-94-1
Inquiry

3. ACVHEL013 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNIGX462 route compound structure diagram
    ACNIGX46265399-05-5In Stock
  4. Then
  5. ACVHEL013 route product structure diagram
    ACVHEL013207683-94-1
Inquiry

Comments (0)